Cogent Biosciences Inc

Cogent Biosciences Inc. is a biotechnology company that develops novel precision therapies to treat a wide range of unmet medical needs. Operating on a global scale, the company is committed to improving the lives of patients by discovering therapies for genetically defined diseases. Based in the biotechnology industry, Cogent Biosciences Inc. works with a network of research scientists to provide research, development, and production of medical therapies. The company’s pipeline product portfolio focuses on bezuclastinib, a highly selective and potent KIT inhibitor with the potential to provide solutions for patients fighting genetically driven diseases. Diversify your virtual portfolio by following COGT shares on eToro.